Breathlessness RElief AT HomE (BREATHE): a feasibility cluster randomised controlled trial (cRCT) to test if a definitive cRCT is possible to evaluate the effectiveness and cost-effectiveness of a paramedic-administered breathlessness crisis intervention for people with acute-on-chronic breathlessness compared with usual care

niversity of Hull0 sites42 target enrollmentNovember 11, 2019

Overview

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33816602/ (added 14/04/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36415651/ (added 24/11/2022)

Registry

who.int

Start Date

November 11, 2019

End Date

July 31, 2021

Last Updated

3 years ago

Study Type

Interventional

Sex

All

Sponsor

niversity of Hull

•Paramedic\-participants:
•1\. From a participating ambulance stations
•2\. Able to provide informed consent
•3\. Willing to undergo training and to deliver intervention if so randomised
•4\. Willing to undergo training to participate in study measures and processes
•Patient\-participants:
•1\. In their normal home environment experiencing a breathlessness crisis and receiving a 999 ambulance response from participating paramedics
•2\. Who do not require immediate life\-saving intervention/transfer to ED in the opinion of the attending paramedic
•3\. Call\-out due to breathlessness
•4\. Who experience chronic breathlessness (defined as short of breath most days in the last 3 months or longer)

•Paramedic\-participants:
•1\. Failure of inclusion criteria
•Patient\-participants:
•1\. Patients requiring urgent disease\-directed intervention and transfer to the ED for acute pathology in the opinion of the attending paramedic
•2\. Patient does not have capacity to provide retrospective consent
•3\. Patient is currently enrolled on the trial or has previously participated